Literature DB >> 16038717

Correlation of plasma von Willebrand factor levels, an index of endothelial damage/dysfunction, with two point-based stroke risk stratification scores in atrial fibrillation.

Vanessa Roldán1, Francisco Marín, Ana García-Herola, Gregory Y H Lip.   

Abstract

To test the hypothesis that the new CHADS2 and Framingham point-based risk stratification scores could be related to plasma vWf (a plasma index of endothelial damage/dysfunction) and soluble E-selectin (an index of endothelial activation) levels in a large cohort of AF patients, we studied 200 consecutive patients (101 male; 72+/-9 years) attending our anti-coagulation clinic for the initiation of anticoagulation treatment with acenocoumarol. AF patients had a median CHADS2 score of 2 (1-2) and a median Framingham point-based risk score of 14 (9-21). Results of research indices in our AF patients were as follows: vWf 142.8+/-41.8 IU/dL and sE-sel 44 (31-62) ng/mL. There were significant correlations between plasma vWf levels and both risk CHADS2 and Framingham risk scores (vWf-CHADS2 risk score: Spearman, r=0.249, p<0.001; vWf-Framingham risk score: r=0.294, p<0.001). sE-sel did not show any significant correlation with both risk scores (sE-sel-CHADS2 risk score: r=-0.054, p=0.460; sE-sel-Framingham risk score: r=0.062, p=0.460). There were no statistically significant correlations between vWf and sE-sel (r=-0.127, p=0.081). Both CHADS2 and Framingham risk scores were significantly correlated with each other, r=0.627, p<0.001. In conclusion, in a wide cohort of non-selected and consecutive AF patients, endothelial damage/dysfunction (assessed by plasma vWf levels) but not endothelial activation (sE-sel) correlated with two new risk stratification scores for stroke in AF. Further prospective studies are needed to assess the prognostic role of prothrombotic indices in AF in relation to stroke and thromboembolic events, and their role in complementing clinical risk stratification schemas.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16038717     DOI: 10.1016/j.thromres.2005.01.005

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  11 in total

1.  Von Willebrand Factor: Multimeric Structure and Functional Activity in Patients With Atrial Fibrillation With and Without Oral Anticoagulation.

Authors:  Sandra Lopez-Castaneda; Ignacio Valencia-Hernández; Carlos Arean; Daniel Godínez-Hernández; Martha Eva Viveros-Sandoval
Journal:  Clin Appl Thromb Hemost       Date:  2017-06-15       Impact factor: 2.389

Review 2.  von Willebrand factor: an emerging target in stroke therapy.

Authors:  Simon F De Meyer; Guido Stoll; Denisa D Wagner; Christoph Kleinschnitz
Journal:  Stroke       Date:  2011-12-15       Impact factor: 7.914

3.  Prothrombotic risk factors and antithrombotic therapy in children with ischemic stroke.

Authors:  Azza A Eltayeb; Gamal A Askar; Naglaa H Abu Faddan; Taghreed M Kamal
Journal:  Ther Adv Neurol Disord       Date:  2015-03       Impact factor: 6.570

Review 4.  Ischaemic stroke: a thrombo-inflammatory disease?

Authors:  Bernhard Nieswandt; Christoph Kleinschnitz; Guido Stoll
Journal:  J Physiol       Date:  2011-07-18       Impact factor: 5.182

5.  Genetic Drivers of von Willebrand Factor Levels in an Ischemic Stroke Population and Association With Risk for Recurrent Stroke.

Authors:  Stephen R Williams; Fang-Chi Hsu; Keith L Keene; Wei-Min Chen; Godfrey Dzhivhuho; Joe L Rowles; Andrew M Southerland; Karen L Furie; Stephen S Rich; Bradford B Worrall; Michèle M Sale
Journal:  Stroke       Date:  2017-05-11       Impact factor: 7.914

6.  Effect of Ginkgo leaf extract on vascular endothelial function in patients with early stage diabetic nephropathy.

Authors:  Xu-Sheng Li; Wei-Ying Zheng; Shi-Xian Lou; Xiao-Wen Lu; Shang-He Ye
Journal:  Chin J Integr Med       Date:  2009-03-07       Impact factor: 1.978

Review 7.  Von Willebrand Factor Plasma Levels Variability In Nonvalvular Atrial Fibrillation.

Authors:  Gerardo Muñoz Cortés; Martha Eva Viveros Sandoval; Carlos Arturo Areán Martínez; Helios Eduardo Vega Gómez; Sandra Edith López Castañeda; Anel Gómez García
Journal:  J Atr Fibrillation       Date:  2014-12-31

8.  The serum levels of MMP-9, MMP-2 and vWF in patients with low doses of urokinase peritoneal dialysis decreased uremia complicated with cerebral infarction.

Authors:  Shu-Jin Wang; Zhong-Sen Qu; Qing-De Zhang; Liang Li; Feng Wang; Bin Zhang; Bang-Li Wu; Yu-Wu Zhao
Journal:  Int J Clin Exp Med       Date:  2015-08-15

9.  Vascular effects of ultrafine particles in persons with type 2 diabetes.

Authors:  Judith C Stewart; David C Chalupa; Robert B Devlin; Lauren M Frasier; Li-Shan Huang; Erika L Little; Steven M Lee; Richard P Phipps; Anthony P Pietropaoli; Mark B Taubman; Mark J Utell; Mark W Frampton
Journal:  Environ Health Perspect       Date:  2010-09-07       Impact factor: 9.031

10.  Von Willebrand factor regulation in patients with acute and chronic cerebrovascular disease: a pilot, case-control study.

Authors:  Peter Kraft; Christiane Drechsler; Ignaz Gunreben; Bernhard Nieswandt; Guido Stoll; Peter Ulrich Heuschmann; Christoph Kleinschnitz
Journal:  PLoS One       Date:  2014-06-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.